---
schema_version: "secwatch.filing_event.v1"
accession: "0001625297-26-000008"
form_type: "8-K"
ticker: "INDV"
cik: "0001625297"
company_name: "Indivior Pharmaceuticals, Inc."
filed_at: "2026-03-12T23:59:59+00:00"
generated_at: "2026-05-15T13:31:51.892485+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Indivior announces $400M convertible senior notes offering due 2031; to repay term loan and repurchase up to $75M stock

## Summary
- $400M aggregate principal amount of convertible senior notes due 2031, with initial purchasers' option for additional $60M.
- Notes are senior unsecured, pay semi-annual interest, redeemable after March 20, 2029 if stock exceeds 130% of conversion price.
- Net proceeds used to repay $239M term loan plus $102M cash, repurchase up to $75M of stock from note purchasers, and general corporate purposes.
- Conversions settled in cash and possibly shares; noteholders can require repurchase on fundamental change.
- Offering is private under Rule 144A; notes and conversion shares not registered under Securities Act.

## SEC filing metadata
- accession: 0001625297-26-000008
- form_type: 8-K
- ticker: INDV
- cik: 0001625297
- company_name: Indivior Pharmaceuticals, Inc.
- filed_at: 2026-03-12T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625297/000162529726000008/0001625297-26-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625297/000162529726000008/indv-20260312.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001625297-26-000008
- JSON: https://secwatch.observer/filing/0001625297-26-000008.json
- Plain text: https://secwatch.observer/filing/0001625297-26-000008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.